Cancer survival in England by stage

Document type
Corporate author(s)
National Cancer Intelligence Network
Public Health England
Date of publication
26 August 2014
Health Services
Social welfare
Material type

Download (237KB )

This preliminary report presents a brief summary of the main variation in 1-year relative survival of the selected cancer types by stage, sex, age, and socio-economic deprivation. It shows that cancer survival in England for breast, lung, prostate, colorectal and ovarian cancer continues to improve.

A comparison of all-stage relative survival in 2012 with a baseline of 2004 to 2007 shows increasing survival across all cancer types. Lung cancer survival has risen from 28% to 36.3%, ovarian cancer survival from 68.1% to 74.7%, colorectal cancer survival from 71.5% to 77.7%, prostate cancer survival from 93.1% to 96.6% and breast cancer survival from 94.8% to 96.4%.